Seer, Inc. (California) (SEER)
2.04
+0.01
(+0.49%)
USD |
NASDAQ |
Aug 24, 16:00
2.04
0.00 (0.00%)
After-Hours: 20:00
Seer Enterprise Value : -17.65M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | -17.65M |
| August 21, 2026 | -18.20M |
| August 20, 2026 | -18.76M |
| August 19, 2026 | -17.10M |
| August 18, 2026 | -18.76M |
| August 17, 2026 | -18.20M |
| August 14, 2026 | -15.44M |
| August 13, 2026 | -14.33M |
| August 12, 2026 | -12.12M |
| August 11, 2026 | -11.01M |
| August 10, 2026 | -11.01M |
| August 07, 2026 | -10.46M |
| August 06, 2026 | -9.355M |
| August 05, 2026 | -9.355M |
| August 04, 2026 | -8.249M |
| August 03, 2026 | -6.590M |
| July 31, 2026 | -7.696M |
| July 30, 2026 | -16.54M |
| July 29, 2026 | -15.44M |
| July 28, 2026 | -12.12M |
| July 27, 2026 | -21.52M |
| July 24, 2026 | -21.52M |
| July 23, 2026 | -17.10M |
| July 22, 2026 | -15.99M |
| July 21, 2026 | -14.33M |
| Date | Value |
|---|---|
| July 20, 2026 | -17.65M |
| July 17, 2026 | -10.46M |
| July 16, 2026 | -11.01M |
| July 15, 2026 | -11.01M |
| July 14, 2026 | -11.01M |
| July 13, 2026 | -10.46M |
| July 10, 2026 | -10.46M |
| July 09, 2026 | -8.802M |
| July 08, 2026 | -9.908M |
| July 07, 2026 | -7.696M |
| July 06, 2026 | -9.355M |
| July 02, 2026 | -40.88M |
| July 01, 2026 | -40.32M |
| June 30, 2026 | -38.66M |
| June 29, 2026 | -52.23M |
| June 26, 2026 | -52.23M |
| June 25, 2026 | -48.38M |
| June 24, 2026 | -50.58M |
| June 23, 2026 | -48.38M |
| June 22, 2026 | -46.73M |
| June 18, 2026 | -47.83M |
| June 17, 2026 | -48.93M |
| June 16, 2026 | -49.48M |
| June 15, 2026 | -49.48M |
| June 12, 2026 | -48.93M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Champions Oncology, Inc. | 68.87M |
| Medpace Holdings, Inc. | 16.90B |
| Avantor, Inc. | 13.04B |
| Personalis, Inc. | 1.640B |
| Adaptive Biotechnologies Corp. | 4.138B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.90M |
| Revenue (Quarterly) | 3.102M |
| Total Expenses (Quarterly) | 20.00M |
| EPS Diluted (Quarterly) | -0.3063 |
| Gross Profit Margin (Quarterly) | 48.55% |
| Profit Margin (Quarterly) | -544.8% |
| Earnings Yield | -59.62% |
| Normalized Earnings Yield | -59.62 |